References
- Xiao Q, Wang R, Wu H, Kuang W, Meng W, Cheng Z. Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients. J Multidisciplinary Healthcare. 2024;17:1127–1135. doi:10.2147/JMDH.S453429
- Teng MLP, Ng CH, Huang DQ, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29(supp1):32–42. doi:10.3350/CMH.2022.0365
- Chen X, Peng R, Peng D, Xiao J, Liu D, Li R. An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? Why is this subject of interest? Front Cell Infect Microbiol. 2023;13:1–11. doi:10.3389/fcimb.2023.1282956
- Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–1986. doi:10.1097/HEP.0000000000000520
- Stefan N, Häring HU. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nature Med. 2013;19(4):394–395. doi:10.1038/nm.3116
- Boeckmans J, Rombaut M, Demuyser T, et al. Infections at the nexus of metabolic-associated fatty liver disease. Arch Toxicol. 2021;95(7):2235–2253. doi:10.1007/s00204-021-03069-1